These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20170836)

  • 1. Tarenflurbil for Alzheimer's disease: a "shot on goal" that missed.
    Vellas B
    Lancet Neurol; 2010 Mar; 9(3):235-7. PubMed ID: 20170836
    [No Abstract]   [Full Text] [Related]  

  • 2. Tarenflurbil: a shot on goal.
    Aisen PS
    Lancet Neurol; 2008 Jun; 7(6):468-9. PubMed ID: 18450518
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
    Geerts H
    IDrugs; 2007 Feb; 10(2):121-33. PubMed ID: 17285465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the diagnosis and treatment of Alzheimer's disease.
    Salloway S
    Med Health R I; 2006 May; 89(5):166-8. PubMed ID: 16764297
    [No Abstract]   [Full Text] [Related]  

  • 5. γ-Secretase modulator in Alzheimer's disease: shifting the end.
    Xia W; Wong ST; Hanlon E; Morin P
    J Alzheimers Dis; 2012; 31(4):685-96. PubMed ID: 22710916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why did tarenflurbil fail in Alzheimer's disease?
    Imbimbo BP
    J Alzheimers Dis; 2009; 17(4):757-60. PubMed ID: 19542625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroflurbiprofen (NicOx).
    Scatena R
    Curr Opin Investig Drugs; 2004 May; 5(5):551-6. PubMed ID: 15202730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent.
    Stock N; Munoz B; Wrigley JD; Shearman MS; Beher D; Peachey J; Williamson TL; Bain G; Chen W; Jiang X; St-Jacques R; Prasit P
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2219-23. PubMed ID: 16455248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecule of the month. MPC-7869 (Flurizan).
    Drug News Perspect; 2005 Mar; 18(2):141. PubMed ID: 15883622
    [No Abstract]   [Full Text] [Related]  

  • 10. Are we prepared to deal with the Alzheimer's disease pandemic?
    Holtzman JL
    Clin Pharmacol Ther; 2010 Oct; 88(4):563-5. PubMed ID: 20703225
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: Implication for future drug discovery and development for AD.
    Wan HI; Jacobsen JS; Rutkowski JL; Feuerstein GZ
    Clin Transl Sci; 2009 Jun; 2(3):242-7. PubMed ID: 20443898
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs in clinical development for Alzheimer's disease: summary and table.
    Drugs Aging; 2012 Jan; 29(1):73-9. PubMed ID: 22191726
    [No Abstract]   [Full Text] [Related]  

  • 14. Arthritis medication studied for Alzheimer's disease prevention.
    Mayo Clin Womens Healthsource; 2004 Jan; 8(1):3. PubMed ID: 14704602
    [No Abstract]   [Full Text] [Related]  

  • 15. Alzheimer's congress. Further progress on a beta-amyloid vaccine.
    Helmuth L
    Science; 2000 Jul; 289(5478):375. PubMed ID: 10939941
    [No Abstract]   [Full Text] [Related]  

  • 16. What we have learned from the Myriad trials.
    Hendrix SB; Wilcock GK
    J Nutr Health Aging; 2009 Apr; 13(4):362-4. PubMed ID: 19300881
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer's drug.
    Miller G
    Science; 2010 Mar; 327(5971):1309. PubMed ID: 20223954
    [No Abstract]   [Full Text] [Related]  

  • 19. New and emerging treatments for Alzheimer's disease.
    Corbett A; Ballard C
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):147-56. PubMed ID: 22439621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
    van Groen T; Kadish I
    Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.